Brought to you by:
‘COVID-19 sparks diabetic macrophage inflammation’—award-winning paper
When patients with diabetes are infected with coronavirus, specialized macrophage cells—already primed to develop excessive inflammation in this population—are further transformed into a pathologically inflammatory state by a decrease in the enzyme histone methyltransferase, or SETDB2, this year’s SVS Foundation…
Fighting the good fight: The case for multidisciplinary limb salvage in face of increasing diabetes, diversifying nation
Dramatic increases in rates of diabetes—particularly among Black females—through 2060 underscore the importance of a multidisciplinary team approach to limb salvage, according to Vincent Rowe, MD, professor of vascular surgery and endovascular therapy in the Keck School of Medicine at…
Diabetes Awareness Month: The utility of SVS branding fliers for diabetic foot ulcers
November is Diabetes Awareness Month. The Branding Toolkit can help SVS members promote the valuable care they provide those with the disease. One of the three customizable condition fliers currently available covers diabetic foot ulcers (the other two address abdominal…
NYC study shows 50% limb salvage rate in COVID-19 patients with ALI during pandemic peak
Data gathered from patients presenting with acute limb ischemia (ALI) during the peak of the COVID-19 pandemic at the heart of New York City—a U.S. epicenter—demonstrated a 50% rate of limb salvage as well as a 70% 30-day mortality rate,…
Black patients in areas with lowest PAD rates disproportionally at higher risk for amputation
It’s among the most topical areas of discussion in current U.S. cultural life: Black people face disparities in terms of healthcare outcomes. And the recently concluded SVS ONLINE digital conference produced fresh research in the affirmative. Data presented during Scientific…
New paradigm in arteriovenous grafts opens up possibility of novel cure for diabetes
A novel twist to arteriovenous graft platforms—traditionally the preserve of hemodialysis—has the ability to open up a new paradigm of treatment across a host of metabolic disorders like diabetes, a study to be presented at a scientific session on June…
Combining aspirin with rivaroxaban reduces risk equally in presence or absence of diabetes
In stable atherosclerosis, a combination of aspirin plus rivaroxaban provided a similar relative degree of benefit on coronary, cerebrovascular and peripheral endpoints in patients with and without diabetes, a prespecified analysis of the COMPASS trial has shown. It also noted…
Letter from Seattle: Amid COVID-19 pandemic, time to act is long past due
SEATTLE—We live in unprecedented times. On Jan. 19, patient zero arrived in the United States at Seattle-Tacoma International Airport after returning from a visit to his family in Wuhan, China. He tested positive for COVID-19 on Jan. 20. Fast forward…
VRIC agenda taking shape, poster sessions to return
The biology of vascular disease—including molecular mechanisms and the immune system—will take center stage on May 4 in Chicago at the 2020 Vascular Research Initiatives Conference (VRIC) meeting of the Society for Vascular Surgery (SVS). The conference, VRIC Chicago 2020:…